Overall rank by patents
#41,984
Across all tracked assignees
USPTO PatentsView assignee record - 6 granted patents across 1 technology areas, active 2020–2022. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: G06F (ELECTRIC DIGITAL DATA PROCESSING).
The verdict
Next holds 6 US patents across 1 technology areas, rank #41,984 of 50,000 tracked assignees.
Next Pathway Inc. has been granted 6 US utility patents between 2020 and 2022, placing Next Pathway Inc. at rank #41,984 across all assignees tracked by PlainPatent. This portfolio spans 1 distinct Cooperative Patent Classification (CPC) subclasses, averaging 13.8 claims per patent with primary concentration in G06F (ELECTRIC DIGITAL DATA PROCESSING). As a Foreign Corporation, Next Pathway Inc. is one of the more focused assignees in the PatentsView dataset. By volume, Next sits between New Vision Display, Inc. (6 patents, rank #41,980) and Nico IP, Llc (6 patents, rank #41,988) - the closest US assignees by grant volume. The composite Innovation Score of 31.9/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Historical data spans 2020 through 2022, with 6 total grants over that period. Velocity comparisons require five years of historical filings to calibrate. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Next Pathway Inc.'s 13.8 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while specialization in 1 subclass reflects a tightly scoped invention area. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Next Pathway Inc. against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
New Vision Display, Inc.
6 patents
NewBio Therapeutics, Inc.
6 patents
NewPhotonics Ltd.
6 patents
Newronika S.p.A.
6 patents
Next Science, LLC
6 patents
Nexus Pharmaceuticals, Inc.
6 patents
Nexus Technologies, Inc.
6 patents
Nico IP, LLC
6 patents
Next Pathway Inc.
6 patents
What this shows Next holds 6 patents at rank #41,984, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #41,984 in granted patent volume.
Other assignees with the most granted patents in Next's primary technology class.
Next's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
32 Top 61% higher than 39% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2020 | 1 | 16.7% |
| 2021 | 1 | 16.7% |
| 2022 | 4 | 66.7% |
Top 1 of 1 technology areas
Overall rank by patents
#41,984
Across all tracked assignees
31.9 out of 100
How to use this portfolio
Next's 6 grants land it in the top 61% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.